Alnylam Pharmaceuticals (ALNY) Times Interest Earned (2020 - 2025)
Historic Times Interest Earned for Alnylam Pharmaceuticals (ALNY) over the last 6 years, with Q4 2025 value amounting to $2.01.
- Alnylam Pharmaceuticals' Times Interest Earned rose 17463.84% to $2.01 in Q4 2025 from the same period last year, while for Dec 2025 it was $2.41, marking a year-over-year increase of 29306.41%. This contributed to the annual value of $1.99 for FY2025, which is 25922.88% up from last year.
- According to the latest figures from Q4 2025, Alnylam Pharmaceuticals' Times Interest Earned is $2.01, which was up 17463.84% from $8.29 recorded in Q3 2025.
- In the past 5 years, Alnylam Pharmaceuticals' Times Interest Earned registered a high of $8.29 during Q3 2025, and its lowest value of -$7.65 during Q2 2023.
- Over the past 5 years, Alnylam Pharmaceuticals' median Times Interest Earned value was -$3.59 (recorded in 2022), while the average stood at -$2.23.
- Per our database at Business Quant, Alnylam Pharmaceuticals' Times Interest Earned tumbled by 13231.58% in 2024 and then surged by 47047.93% in 2025.
- Over the past 5 years, Alnylam Pharmaceuticals' Times Interest Earned (Quarter) stood at -$5.28 in 2021, then decreased by 19.31% to -$6.31 in 2022, then surged by 41.09% to -$3.71 in 2023, then rose by 27.35% to -$2.7 in 2024, then soared by 174.64% to $2.01 in 2025.
- Its Times Interest Earned stands at $2.01 for Q4 2025, versus $8.29 for Q3 2025 and -$0.4 for Q2 2025.